CO6290791A2 - Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws - Google Patents

Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws

Info

Publication number
CO6290791A2
CO6290791A2 CO10074488A CO10074488A CO6290791A2 CO 6290791 A2 CO6290791 A2 CO 6290791A2 CO 10074488 A CO10074488 A CO 10074488A CO 10074488 A CO10074488 A CO 10074488A CO 6290791 A2 CO6290791 A2 CO 6290791A2
Authority
CO
Colombia
Prior art keywords
seq
nos
virus
porcine circovirus
circus
Prior art date
Application number
CO10074488A
Other languages
English (en)
Spanish (es)
Inventor
Stephen Quitu Wu
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40436491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6290791(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of CO6290791A2 publication Critical patent/CO6290791A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CO10074488A 2007-12-21 2010-06-21 Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws CO6290791A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1589407P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
CO6290791A2 true CO6290791A2 (es) 2011-06-20

Family

ID=40436491

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10074488A CO6290791A2 (es) 2007-12-21 2010-06-21 Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws

Country Status (16)

Country Link
US (2) US20090162398A1 (enExample)
EP (1) EP2225367A1 (enExample)
JP (2) JP2011507522A (enExample)
KR (1) KR20100094587A (enExample)
CN (1) CN101932700A (enExample)
AR (1) AR069882A1 (enExample)
AU (1) AU2008343172B2 (enExample)
BR (1) BRPI0821286A8 (enExample)
CA (1) CA2710247C (enExample)
CL (1) CL2008003813A1 (enExample)
CO (1) CO6290791A2 (enExample)
ME (1) ME01156B (enExample)
NZ (1) NZ586238A (enExample)
RU (1) RU2493254C9 (enExample)
UA (1) UA99495C2 (enExample)
WO (1) WO2009085912A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CN102711816A (zh) * 2009-10-22 2012-10-03 莱比锡大学 患有牛新生儿全血细胞减少症的小牛中的圆环病毒的检测
EP2528931A4 (en) * 2010-01-25 2013-12-04 Blood Systems Inc CYCLOVIRUS AND USE METHOD THEREFOR
HRP20200258T1 (hr) 2010-03-16 2020-09-04 Virginia Tech Intellectual Properties Inc Živo atenuirano himerno cjepivo protiv svinjskog cirkovirusa
CA2804604C (en) * 2010-07-08 2023-10-03 United Biomedical, Inc. Designer peptide-based pcv2 vaccine
CN101920012B (zh) * 2010-07-22 2012-12-12 普莱柯生物工程股份有限公司 利用家蚕生物反应器生产猪圆环病毒2型重组衣壳蛋白亚单位疫苗的方法及其产品
KR101030792B1 (ko) * 2010-09-16 2011-04-27 주식회사 코미팜 돼지 써코바이러스２(ｐｃｖ２) 유전자의 표면발현용 벡터 및 이로 형질전환된 살모넬라 백신 균주
CN102199571B (zh) * 2011-04-06 2013-07-31 华中农业大学 一种表达猪2型圆环病毒orf2基因片段的重组支气管败血波氏杆菌株、疫苗及应用
CN102988978B (zh) * 2011-08-01 2016-02-03 普莱柯生物工程股份有限公司 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
HUP1100470A2 (en) 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
EP2564869A1 (en) 2011-09-02 2013-03-06 Ceva Sante Animale Synthetic capsid proteins and uses thereof
CN103083655B (zh) * 2011-11-02 2015-08-26 普莱柯生物工程股份有限公司 预防和治疗猪圆环病毒2型、副猪嗜血杆菌和猪肺炎支原体感染的疫苗组合物及其制备方法
CN102517331A (zh) * 2011-12-26 2012-06-27 武汉中博生物股份有限公司 一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用
CN103033622B (zh) * 2011-12-26 2015-03-25 武汉中博生物股份有限公司 猪圆环病毒2型elisa抗原检测试剂盒及其制备方法和其应用
US9474692B2 (en) 2012-01-13 2016-10-25 Boehringer Ingelheim Vetmedica Gmbh Kit for the preparation of a vaccinating agent
CN104735977B (zh) 2012-06-12 2016-09-21 替代基因表达公司 用于在宿主细胞中表达重组蛋白的杆状病毒dna元件
JP6364007B2 (ja) 2012-08-17 2018-07-25 インターベット インターナショナル ベー． フェー． 不活化レプトスピラ細菌の免疫原性組成物
CN102824634B (zh) * 2012-09-14 2014-03-19 范红结 表达猪圆环病毒2型Cap蛋白的重组猪痘病毒载体疫苗及其制备方法
CN103920146A (zh) * 2013-01-14 2014-07-16 普莱柯生物工程股份有限公司 猪圆环病毒ⅱ型与猪伪狂犬病二联疫苗及其制备方法和应用
BR102013001893B1 (pt) * 2013-01-25 2022-01-25 Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig Antígenos recombinantes do porcine circovirus 2 (pcv-2) para formulações vacinais, kit de diagnóstico e uso
EP2789346A1 (en) 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusion polypeptides and vaccines
CN103275938B (zh) * 2013-05-07 2015-02-25 上海市农业科学院 猪圆环病毒弱毒疫苗株的制备方法
DK2994162T3 (en) 2013-05-08 2021-06-21 Pharmgate Biologics Inc Vaccine for pcv2 og mycoplasma
EP3035958B1 (en) 2013-08-23 2022-10-26 Boehringer Ingelheim Animal Health USA Inc. Porcine circovirus type 2 (pcv2) subunit vaccine
RU2662685C2 (ru) * 2013-09-25 2018-07-26 Зоэтис Сервисиз Ллс Pcv2b дивергентная вакцинная композиция и способы её применения
KR20220083861A (ko) 2013-10-02 2022-06-20 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN104250640A (zh) 2014-08-22 2014-12-31 普莱柯生物工程股份有限公司 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
CN105709220B (zh) * 2014-12-03 2020-03-31 普莱柯生物工程股份有限公司 用于猪圆环病毒与猪流感的疫苗组合物及制备方法和应用
EP3034609A1 (en) 2014-12-19 2016-06-22 Ceva Sante Animale Recombinant swinepox virus and vaccines
CN104984335A (zh) * 2015-07-14 2015-10-21 浙江诺倍威生物技术有限公司 猪圆环病毒双亚型orf2共表达载体构建及疫苗制备
JP7088835B2 (ja) * 2015-10-16 2022-06-21 カンザス ステイト ユニバーシティ リサーチ ファウンデーション ブタサーコウイルス３型免疫原性組成物、その製造方法、およびその使用方法
MY191905A (en) * 2015-12-28 2022-07-18 Boehringer Ingelheim Animal Health Usa Inc M hyo multivalent vaccine and uses thereof
CN105785037B (zh) * 2016-03-30 2017-09-19 中国农业科学院兰州兽医研究所 猪圆环病毒2型抗体快速检测层析试纸条及制备方法
EP3254692A1 (en) 2016-06-10 2017-12-13 Ceva Sante Animale Multivalent recombinant spv
CN106435016B (zh) * 2016-08-30 2019-07-26 中国农业科学院兰州兽医研究所 一种快速显色一步法检测猪圆环病毒2型的lamp试剂盒
CN107937354A (zh) * 2017-11-10 2018-04-20 南京天邦生物科技有限公司 2型猪圆环病毒及其应用
US20200390878A1 (en) 2017-12-08 2020-12-17 Ceva Sante Animale Recombinant swinepox virus and vaccines
KR102133632B1 (ko) * 2018-03-29 2020-07-13 충남대학교산학협력단 재조합 돼지 써코바이러스 및 이를 포함하는 돼지 써코바이러스 감염 질환의 예방용 백신 조성물
JP2021527073A (ja) 2018-06-11 2021-10-11 セヴァ サンテ アニマレＣｅｖａ Ｓａｎｔｅ Ａｎｉｍａｌｅ ブタサーコウイルスに対するワクチン接種
CN109381696A (zh) * 2018-08-27 2019-02-26 长沙创西生物科技有限公司 一种用于防治猪圆环病毒病的缓释微囊的制备方法
CN111088396A (zh) * 2019-11-14 2020-05-01 河南科技学院 一种同时检测副猪嗜血杆菌、猪细小病毒、猪圆环病毒2型的三重实时荧光pcr方法
RU2747468C1 (ru) * 2020-06-23 2021-05-05 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Способ получения вакцины против цирковируса свиней (варианты)
CN113907044A (zh) * 2021-11-09 2022-01-11 福建省连江县刘氏兔业养殖场 一种抗病猪品系的培育方法及其应用
CN115820840A (zh) * 2022-11-23 2023-03-21 武汉轻工大学 一种副猪嗜血杆菌感染后引起仔猪免疫抑制的分子标记物
US20250332242A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708871A (en) * 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US5238662A (en) * 1987-07-31 1993-08-24 Chevron Research Company Processes for recovering precious metals
US5147966A (en) * 1990-07-31 1992-09-15 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polyimide molding powder, coating, adhesive and matrix resin
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2769322B1 (fr) * 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
CA2442135C (en) * 2001-03-27 2008-08-19 University Of Saskatchewan Methods to culture circovirus
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
DK2371383T3 (en) * 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs

Also Published As

Publication number Publication date
RU2493254C2 (ru) 2013-09-20
ME01156B (me) 2013-03-20
JP2011507522A (ja) 2011-03-10
CA2710247A1 (en) 2009-07-09
CN101932700A (zh) 2010-12-29
CA2710247C (en) 2014-02-18
AU2008343172A1 (en) 2009-07-09
RU2010124791A (ru) 2012-01-27
BRPI0821286A8 (pt) 2017-08-15
JP2017060473A (ja) 2017-03-30
WO2009085912A1 (en) 2009-07-09
CL2008003813A1 (es) 2009-03-20
US20090162398A1 (en) 2009-06-25
EP2225367A1 (en) 2010-09-08
BRPI0821286A2 (pt) 2014-10-14
AR069882A1 (es) 2010-02-24
KR20100094587A (ko) 2010-08-26
US20110305725A1 (en) 2011-12-15
AU2008343172B2 (en) 2015-02-19
NZ586238A (en) 2012-10-26
RU2493254C9 (ru) 2013-12-20
UA99495C2 (ru) 2012-08-27

Similar Documents

Publication Publication Date Title
CO6290791A2 (es) Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws
CL2019003842A1 (es) Vectores virales recombinantes con tropismo modificado y usos de estos para la introducción dirigida de material genético a células humanas.
CO2020004738A2 (es) Variantes de cápsides de virus adenoasociados y métodos de uso de estas
CO2021010088A2 (es) Construcciones de terapia génica para el tratamiento de la enfermedad de wilson
AR065076A1 (es) Vacuna contra el papilomavirus
CO6531435A2 (es) Nuevas formulaciones de vacuna que comprende adyuvantes que contienen saponina
AR133161A2 (es) Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos
AR079526A1 (es) Vacuna multivalente contra los teschovirus porcinos y otros organismos que provocan enfermedades en los cerdos
MX2020006764A (es) Una proteína de la cápside de raav modificada para terapia génica.
AR083839A1 (es) Virus del sindrome reproductivo y respiratorio porcino (prrs) de los estados unidos y sus usos
CL2011001343A1 (es) Pestivirus quimerico que comprende un virus de la diarrea viral bovina (bvdv) que expresa proteina erns de antilope; celula huesped que lo comprende; acido nucleico que lo codifica; composicion inmunogenica que comprende el pestivirus; vacuna marcadora que comprende el bvdv quimerico.
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
BR112016006192A2 (pt) composição de vacina de divergente de pcv2b e métodos de uso
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
PE20091355A1 (es) Paramixovirus oncoliticos atenuados que codifican citoquinas de aves
CO2018010874A2 (es) Vacuna de virus de zika atenuado vivo
CL2013001877A1 (es) Composicion inmunogenica que comprende un virus de diarrea viral bovina tipo 1b vivo modificado y un portador veterinario aceptable; vacuna que la comprende; y su uso para prevenir, tratar, manejar o aliviar uno o mas sintomas de una enfermedad causada por pestivirus.
CL2021002582A1 (es) Vacunas contra el circovirus porcino tipo 3 (pcv3), su producción y usos
CO2019010062A2 (es) Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
CL2021003211A1 (es) Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018)
BRPI0920622A8 (pt) vacina contra o vírus da doença equina africana
CO2017001614A2 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
CO6541529A2 (es) Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos
AR124461A1 (es) VACUNA BASADA EN AAV5 PARA LA INDUCCIÓN DE INMUNIDAD ESPECÍFICA CONTRA EL SARS-CoV-2 Y/O LA PREVENCIÓN DE LA INFECCIÓN POR CORONAVIRUS RELACIONADA CON EL SARS-CoV-2

Legal Events

Date Code Title Description
FC Application refused